References
- Boyce GM, Causey W. Increasing occurrence of methi-cillin resistant S. aureus in the United States. Infect Control 1982; 3: 377–383.
- Venditti M, Baiocchi P, Brandimarte C et al. High rate of oxacillin-resistant S. aureus isolates in an Italian University Hospital. J Chemother 1994; 3: 25–28.
- Voss A, Milatovic D, Wallranch-Schwarz C, Rosdahl VT, Braveny I. Methicillin-resistant S. aureus in Europe. Eur J Clin Microbiol Infect Dis 1994; 13: 50–55.
- Baiocchi P, Capone A, Di Rosa R, Penni A, Santini C, Venditti M. Surveillance study on S. aureus in Rome: prelimi-nary data on the frequency of oxacillin resistance among nosocomial and community isolates. Microecol Ther 1995; 25: 373–376.
- National Committee for Clinical Laboratory Standards. Performance standards for antimicrobial disk susceptibility test-ing. Approved standard. NCCLS Publication M2-A5, Villanova, PA, 1993.
- Thornsberry C, McDougal LK. Successful use of broth microdilution in susceptibility test for methicillin-resistant (het-eroresistant) staphylococci. J Clin Microbiol 1983; 18: 1084–1091.
- National Committee for Clinical Laboratory Standards. Procedures for susceptibility testing of aerobic bacteria. Approved standard. NCCLS Publication M7-A3. Villanova, PA: 1993.
- Armitage P. Statistical methods in clinical research. 1st ed. Oxford: Blackwell Scientific Publications, 1971.
- Santini C, Baiocchi P, Venditti M et al. Aorto-femoral graft infections: a clinical and microbiological analysis. J Infect 1993; 27: 17–26.
- Venditti M, Baiocchi P, Santini C et al. Potential of clindamycin in addition to vancomycin for the treatment of oxacillin-resistant S. aureus septicemia persisting under van-comycin therapy. Int J Antimicrob Agents 1995; 5: 123–128.
- Venditti M, Carfagna P, Plastino AR et al. S. aureus in neurosurgery adult patients: a retrospective clinical and micro-biological analysis. Infect Dis Clin Practice, Infect Dis Clin Pract 1996; 5: 325–330.
- Faville RJ, Kaske DE, Kaplan EL, Crossley K, Sabath LD, Anie PG. S. aureus endocarditis. Continued therapy with vancomycin and rifampin. JAMA 1978; 240: 1963–1965.
- Cuard C, Hermann M, Vandaux P, Waldvogel FA, Lew DP. Successful treatment of methicillin-resistant S. aureus by antimicrobial combinations. Antimicrob Agents Chemother 1991; 35: 2611–2616.
- Goering RW, Fey PD, Goldstein FW. Usefulness of pulsed field electrophoresis in epidemiological analysis of S. aureus isolates witih decreased susceptibility to teicoplanin. Eur J Clin Microbiol Infect Dis 1995; 14 (suppl 1): 3-5.
- Baiocchi P, Capone A, Carfagna P, Santini C, Venditti M. Changes in susceptibilities to teicoplanin, vancomycin and other antibiotics among S. aureus isolates in a tertiary-care University hospital. Int J Antimicrob Agents, in press.
- Gopal V, Bisno Al, Sirveblatt FJ. Failure of vancomycin treatment in S. aureus endocarditis. JAMA 1976; 236: 1604–1605.
- Gilbert DN, Wood CA, Kimbrough RC and the Infectious Diseases Consortium of Oregon. Failure of treat-ment with teicoplanin at 6 mg/kg/day in patients with S. aureus intravascular infection. Antimicrob Agents Chemother 1991; 35: 79–87.
- Levine DP, Fromm BS, Reddy BR. Slow response to vancomycin or vancomycin plus rifampicin therapy among patients with methicillin-resistant S. aureus. Ann Intern Med 1991; 115: 674–680.